Biosynex SA reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 92.98 million compared to EUR 196.59 million a year ago. Net loss was EUR 36.95 million compared to net income of EUR 15.66 million a year ago.

Basic loss per share from continuing operations was EUR 3.45 compared to basic earnings per share from continuing operations of EUR 1.53 a year ago. Diluted loss per share from continuing operations was EUR 3.45 compared to diluted earnings per share from continuing operations of EUR 1.52 a year ago.